Plasma volume expansion from the intravenous glucose tolerance test before and after hip replacement surgery

Plasma Volume Expansion Resulting from Intravenous Glucose Tolerance Test

OBJECTIVE To quantify the degree of plasma volume expansion that occurs during an intravenous glucose tolerance test (IVGTT). METHODS Twenty healthy volunteers (mean age, 28 years) underwent IVGTTs in which 0.3 g/kg of glucose 30% was injected as a bolus over 1 min. Twelve blood samples were collected over 75 min. The plasma glucose and blood hemoglobin concentrations were used to calculate t...

Intravenous Glucose Tolerance Test in Normal Persons

as a supplement to the oral method has been pointed out by many workers. Moreover, the possibility of error in the result of oral method due to diminished absorption has been shown by Beeler, Bryan, Cathcart and Fitz (1922). The flat blood sugar curve obtained by Thaysen (1929) after the oral administration of glucose, as has been shown by the author, is due to the diminished absorption of gluc...

A standard intravenous glucose tolerance test.

Intravenous Glucose Tolerance Test and Glucose Kinetic Parameters in Rabbits

The purpose of this study was to determine the normal range and test variability for intravenous glucose tolerance test (IVGTT) in rabbits. Fifty one clinically healthy New Zealand white rabbits of both sexes (31 female and 20 male), 3.5−4 months of age and weighing 2.8 to 3.7 kg were used. The IVGTT was performed after an overnight fasting period of 12 h by intravenous injection of 40% glucose...

Mortality after total hip replacement surgery

Total hip replacement causes a short-term increase in the risk of mortality. It is important to quantify this and to identify modifiable risk factors so that the risk of post-operative mortality can be minimised. We performed a systematic review and critical evaluation of the current literature on the topic. We identified 32 studies published over the last 10 years which provide either 30-day o...